Dr Reddys Laboratories (RDY) Long-Term Debt Repayments (2009)
Dr Reddys Laboratories (RDY) posted quarterly Long-Term Debt Repayments of -$22.0 million for Q4 2009, down 29.41% quarter-over-quarter from -$17.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Long-Term Debt Repayments (2009) Analysis & Trends
Dr Reddys Laboratories' Long-Term Debt Repayments history runs 1 years deep, the most recent figure standing at -$22.0 million for Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -156,847.56 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | -22.00 Mn |
| Dec 31, 2009 | -22.00 Mn |
| Sep 30, 2009 | -17.00 Mn |
| Sep 30, 2009 | -17.00 Mn |
| Jun 30, 2009 | -17.00 Mn |
| Jun 30, 2009 | -17.00 Mn |